Nisa Investment Advisors’s Elevation Oncology ELEV Stock Holding History

Nisa Investment Advisors’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,961	Closed	-$720	–	3015
2025 Q2	$720	Buy	+1,961	New	+$655	﹤0.01%	2803
2025 Q1	–	Sell	-1,162	Closed	-$654	–	3008
2024 Q4	$654	Buy	1,162 +1,015	+690%	+$599	﹤0.01%	2770
2024 Q3	$88	Buy	+147	New	+$218	﹤0.01%	2914

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Nisa Investment Advisors's ELEV Position: Q3 2025 in Review

Nisa Investment Advisors sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 1,961 shares — an estimated $720 sold.

Nisa Investment Advisors first reported a position in ELEV in Q3 2024 and held it in 3 quarters. The position peaked at $720 in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Nisa Investment Advisors reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Nisa Investment Advisors sold 1,961 Elevation Oncology shares in Q3 2025, an estimated $720.
Nisa Investment Advisors first reported a position in Elevation Oncology in Q3 2024 and held it in 3 quarters.
Nisa Investment Advisors's Elevation Oncology position peaked at $720 in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.